...
首页> 外文期刊>Journal of Functional Foods >Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies
【24h】

Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies

机译:促进肠道中新兴益生菌丰富的Akkermansia muciniphila的策略,饮食干预研究的证据

获取原文
获取原文并翻译 | 示例

摘要

Akkermansia muciniphila is a mucin-degrading bacterium commonly found in human gut. A. muciniphila has been inversely associated with obesity, diabetes, inflammation, and metabolic disorders. Due to its highly promising probiotic activities against obesity and diabetes, A. muciniphila has drawn intensive interest for research and development in recent years. A number of human and animal studies have shown that the abundance of A. muciniphila in the gut can be enhanced through dietary interventions. The present review focuses on evidence-based dietary strategies of improving A muciniphila abundance in the gut by critically appraising up-to-date available human and animal intervention studies on A. mudniphila growth and their impact on risk factors of obesity and diabetes. Their potential mechanisms in promoting A. muciniphila are also discussed along with the discussions of mechanism of action for A. muciniphila to exert probiotic functions. (C) 2017 Published by Elsevier Ltd.
机译:Akkermansia粘蛋白是一种常见于人体肠道的粘蛋白降解细菌。 A. muciniphila与肥胖,糖尿病,炎症和代谢紊乱相反。 由于其对肥胖和糖尿病的高益生菌活动,A.Muciniphila近年来对研发的密集感兴趣。 许多人和动物研究表明,通过饮食干预可以提高肠道中A.粘蛋白的丰度。 本综述侧重于通过对A. Mudniphila增长的最新可用的人和动物干预研究及其对肥胖和糖尿病危险因素的影响来改善肠道中粘蛋白丰富的基于证据的饮食策略。 还讨论了促进A.粘蛋白的潜在机制。随着对粘蛋白的作用机制促使益生菌功能的讨论。 (c)2017年由elestvier有限公司出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号